Unidad de Investigación Clínica de Oncohematología Pediátrica IdiPAZ-CNIO

Inicio | Investigación e innovación | Programas Científicos | Programa de Investigación Clínica | Unidad de Investigación Clínica de Oncohematología Pediátrica IdiPAZ-CNIO

Antonio Pérez
Antonio Pérez Jefe de Unidad de Investigación Clínica
T +34 917328000 (Ext )
anperezm@ext.cnio.es

Investigadores Científicos

  • Víctor Galán

Investigador Clínico I

  • Carmen Mestre

Becarios Post-doctorales

  • Cristina Aguirre
  • Alfonso Alba
  • Halin Bareke
  • Elisa Pilar Izquierdo
  • Adriana Mañas
  • Jordi Minguillón
  • Andrés París
  • Odelaisy León Triana

Becarios Pre-Doctorales

  • Karima Al Akioui
  • Álvaro Blázquez
  • Laura Clares
  • María Octavia de Santisteban
  • Esther Díaz Maroto
  • Mikel Fernández
  • Sara Fernández
  • Beatriz García
  • Adrián Ibáñez
  • Marta Ibáñez
  • Beatriz Madroñal
  • Alicia Martín
  • Andrea Matesanz
  • Antonio Jesús Muñoz
  • Sara Naharro
  • Alfonso Navarro
  • Beatriz Ruz
  • Cristina Smith
  • Claudia Suanzes
  • Clara Venegas

Técnicos de Laboratorio

  • Estefania Ayala
  • Lidia Pertiñez
  • Natalia Riestra

The Pediatric Onco-Hematology Clinical Research Unit, headed by Antonio Pérez-Martínez, comprises a multidisciplinary team of physicians, geneticists, biologists, biochemists, and bioinformaticians, who, for the past decade, have carried out projects ranging from knowledge generation to direct clinical application through the development of clinical trials. Our research, which is mostly funded by Fundación Cris Contra el Cáncer, focuses on the design of therapies applied to paediatric oncology, infectious diseases, and paediatric transplantation. Briefly, our research interests include: 1) the use of haematopoietic stem cell transplantation as a platform for cell therapy; 2) the improvement of human stem cell progenitors transplantation in children; 3) cell therapy with memory T lymphocytes as adoptive immunotherapy; and 4) the use of both activated and memory-like NK cells and CART-T cells in paediatric oncology. Together with this, we led several projects aimed at studying the efficacy and feasibility of cell therapy against infectious diseases. Finally, we are also working on the induction of immunological tolerance in solid organ transplantation by inducing mixed haematopoietic chimera through cell therapy. We maintain a strong commitment to patients and to improving their quality of life, having a direct impact on society’s well-being. In this sense, we have several active academic clinical trials and collaborations with industry, with the objective of developing new and more effective therapies with fewer side effects.

Publicaciones

Subir

CNIO
Resumen de privacidad

Esta web utiliza cookies para que podamos ofrecerte la mejor experiencia de usuario posible. La información de las cookies se almacena en tu navegador y realiza funciones tales como reconocerte cuando vuelves a nuestra web o ayudar a nuestro equipo a comprender qué secciones de la web encuentras más interesantes y útiles.